Observational Study Regarding the Combination of Fluoropyrimidine and Bevacizumab in Patients With mCRC

NCT07494578 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer Metastatic

Interventions

DRUG: Fluoropyrimidine

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS